APA (7th ed.) Citation

MA, M., MA, R., MD, G., Y, A., DS, S., S, A., . . . N, S. (2025). Escitalopram oxalate-loaded chitosan nanoparticle in situ gel formulation intended for direct nose-to-brain delivery: In vitro, ex vivo, and in vivo pharmacokinetic evaluation. Frontiers in pharmacology, 16, 1577331. https://doi.org/10.3389/fphar.2025.1577331

Chicago Style (17th ed.) Citation

MA, Mujtaba, et al. "Escitalopram Oxalate-loaded Chitosan Nanoparticle in Situ Gel Formulation Intended for Direct Nose-to-brain Delivery: In Vitro, Ex Vivo, and in Vivo Pharmacokinetic Evaluation." Frontiers in Pharmacology 16 (2025): 1577331. https://doi.org/10.3389/fphar.2025.1577331.

MLA (9th ed.) Citation

MA, Mujtaba, et al. "Escitalopram Oxalate-loaded Chitosan Nanoparticle in Situ Gel Formulation Intended for Direct Nose-to-brain Delivery: In Vitro, Ex Vivo, and in Vivo Pharmacokinetic Evaluation." Frontiers in Pharmacology, vol. 16, 2025, p. 1577331, https://doi.org/10.3389/fphar.2025.1577331.